Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel S Merseburger

Showing results (271-280 of 323) with videos related to

Pageof 33
Sort By:
BJU International|June 28, 2024
Targeted Investigational Treatment Analysis of Novel Anti-androgen (TITAN) study: ultralow prostate-specific antigen decline with apalutamide plus androgen-deprivation therapyAxel S Merseburger, Neeraj Agarwal, Anders Bjartell, et al.
The Journal of Urology|May 27, 2021
Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer: Analysis of Pain and Fatigue in the Phase 3 TITAN StudyNeeraj Agarwal, Kelly McQuarrie, Anders Bjartell, et al.
Cancers|February 25, 2023
Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract CarcinomaPauline Parent, Edouard Auclin, Anna Patrikidou, et al.
European Urology|September 2, 2015
Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour BiopsyLorenzo Marconi, Saeed Dabestani, Thomas B Lam, et al.
The Journal of Urology|July 23, 2021
Reply by AuthorsNeeraj Agarwal, Kelly McQuarrie, Anders Bjartell, et al.
Immunotherapy|June 3, 2021
Adverse events of the second-line treatment for patients with locally advanced or metastatic urothelial carcinoma of the bladder: network meta-analysisEkaterina Laukhtina, Keiichiro Mori, Hadi Mostafaei, et al.
European Urology|December 29, 2015
Systematic Review of Surgical Management of Nonmetastatic Renal Cell Carcinoma with Vena Caval ThrombusMichael Lardas, Fiona Stewart, Duncan Scrimgeour, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2023
Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: A subgroup analysis of the randomised clinical TITAN studyAxel S Merseburger, Neeraj Agarwal, Amitabha Bhaumik, et al.
European Urology|September 5, 2018
Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell CarcinomaAxel Bex, Laurence Albiges, Börje Ljungberg, et al.
The Journal of Urology|November 28, 2015
Oncologic Outcomes of Kidney Sparing Surgery versus Radical Nephroureterectomy for the Elective Treatment of Clinically Organ Confined Upper Tract Urothelial Carcinoma of the Distal UreterThomas Seisen, Laurent Nison, Mezut Remzi, et al.
Pageof 33

Showing results (271-280 of 323) with videos related to

Sort By:
Pageof 33
BJU International|June 28, 2024
Targeted Investigational Treatment Analysis of Novel Anti-androgen (TITAN) study: ultralow prostate-specific antigen decline with apalutamide plus androgen-deprivation therapyAxel S Merseburger, Neeraj Agarwal, Anders Bjartell, et al.
The Journal of Urology|May 27, 2021
Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer: Analysis of Pain and Fatigue in the Phase 3 TITAN StudyNeeraj Agarwal, Kelly McQuarrie, Anders Bjartell, et al.
Cancers|February 25, 2023
Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract CarcinomaPauline Parent, Edouard Auclin, Anna Patrikidou, et al.
European Urology|September 2, 2015
Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour BiopsyLorenzo Marconi, Saeed Dabestani, Thomas B Lam, et al.
The Journal of Urology|July 23, 2021
Reply by AuthorsNeeraj Agarwal, Kelly McQuarrie, Anders Bjartell, et al.
Immunotherapy|June 3, 2021
Adverse events of the second-line treatment for patients with locally advanced or metastatic urothelial carcinoma of the bladder: network meta-analysisEkaterina Laukhtina, Keiichiro Mori, Hadi Mostafaei, et al.
European Urology|December 29, 2015
Systematic Review of Surgical Management of Nonmetastatic Renal Cell Carcinoma with Vena Caval ThrombusMichael Lardas, Fiona Stewart, Duncan Scrimgeour, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2023
Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: A subgroup analysis of the randomised clinical TITAN studyAxel S Merseburger, Neeraj Agarwal, Amitabha Bhaumik, et al.
European Urology|September 5, 2018
Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell CarcinomaAxel Bex, Laurence Albiges, Börje Ljungberg, et al.
The Journal of Urology|November 28, 2015
Oncologic Outcomes of Kidney Sparing Surgery versus Radical Nephroureterectomy for the Elective Treatment of Clinically Organ Confined Upper Tract Urothelial Carcinoma of the Distal UreterThomas Seisen, Laurent Nison, Mezut Remzi, et al.
Pageof 33